Corporate Travel Management (ASX: CTD) – Files Preliminary Final Report 3
Corporate Travel Management Limited reported a dramatic turnaround in FY25, swinging to a loss of $348.5 million after reporting a profit of $19.0...
ASX Announcements
Clinuvel Pharmaceuticals (ASX: CUV) – Clinuvel considers Nasdaq listing and ASX delisting
CLINUVEL Pharmaceuticals has announced that its Board of Directors is considering a significant restructuring that would see the company transition...
Clinuvel Pharmaceuticals (ASX: CUV) – Clinuvel Files Investor Presentation 12
Clinuvel Pharmaceuticals has launched its investor presentation for the financial year ended 30 June 2026, with a stated focus on U.S. expansion...
Clinuvel Pharmaceuticals (ASX: CUV) – Decade of profitability fuels U.S. expansion
Clinuvel Pharmaceuticals has delivered its tenth consecutive annual profit, capping off a decade of commercial operations that has generated a 31%...
Clinuvel Pharmaceuticals (ASX: CUV) – Files 2026 Annual Report and Appendix 4E
Clinuvel Pharmaceuticals reported a year ending 30 June 2026 with revenues declining 1 percent to A$94.0 million and net profit falling 6 percent to...